Gaviscon Double Action Tablets Pilot Efficacy Study

• Research type

  Research Study

• Full title

  A multi-centred, randomised, double-blind, two arm, parallel group, placebo-controlled, pilot study to assess the effect of Gaviscon Double Action Tablets in patients with reflux disease.

• IRAS ID

  102711

• Contact name

  Alan G Wade

• Contact email

  alan.wade@cpsresearch.co.uk

• Sponsor organisation

  Reckitt Benckiser (UK)Ltd

• Eudract number

  2012-002188-84

• Research summary

  This pilot study of Gaviscon Double Action Tablets is to be conducted to provide a basis for further studies in export markets to demonstrate that Gaviscon Double Action Tablets taken regularly are effective in managing the symptoms of heartburn, acid regurgitation and dyspepsia in patients with GERD.

• REC name

  East of Scotland Research Ethics Service REC 2

• REC reference

  12/ES/0061

• Date of REC Opinion

  17 Jul 2012

• REC opinion

  Further Information Favourable Opinion